Literature DB >> 6322800

Halogenated pyrrolopyrimidine analogues of adenosine from marine organisms: pharmacological activities and potent inhibition of adenosine kinase.

L P Davies, D D Jamieson, J A Baird-Lambert, R Kazlauskas.   

Abstract

Two novel halogenated pyrrolopyrimidine analogues of adenosine, isolated from marine sources, have been examined for pharmacological and biochemical activities. 4-Amino-5-bromo-pyrrolo[2,3-d]pyrimidine, from a sponge of the genus Echinodictyum, had bronchodilator activity at least as potent as theophylline but with a different biochemical profile; unlike theophylline it had no antagonist activity at CNS adenosine receptors and it was quite a potent inhibitor of adenosine uptake and adenosine kinase in brain tissue. 5'-Deoxy-5-iodotubercidin, isolated from the red alga Hypnea valentiae, caused potent muscle relaxation and hypothermia when injected into mice. This compound was a very potent inhibitor of adenosine uptake into rat and guinea-pig brain slices and an extremely potent inhibitor of adenosine kinase from guinea-pig brain and rat brain and liver. Neither of these two pyrrolopyrimidine analogues was a substrate for, or an inhibitor of, adenosine deaminase. Neither compound appeared to have any direct agonist activity on guinea-pig brain adenosine-stimulated adenylate cyclase (A2 adenosine receptors). 5'-Deoxy-5-iodotubercidin is unique in two respects: it appears to be the first naturally-occurring example of a 5'-deoxyribosyl nucleoside and is the first example of a specifically iodinated nucleoside from natural sources. It may be the most potent adenosine kinase inhibitor yet described and, by virtue of its structure, may prove to be the most specific.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6322800     DOI: 10.1016/0006-2952(84)90225-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  12 in total

1.  Profound hypothermia after adenosine kinase inhibition in A1AR-deficient mice suggests a receptor-independent effect of intracellular adenosine.

Authors:  Christoph Eisner; SooMi Kim; Alexandra Grill; Yan Qin; Marion Hoerl; Josephine Briggs; Hayo Castrop; Manfred Thiel; Jurgen Schnermann
Journal:  Pflugers Arch       Date:  2016-12-14       Impact factor: 3.657

2.  Discovering new classes of Brugia malayi asparaginyl-tRNA synthetase inhibitors and relating specificity to conformational change.

Authors:  Sai Chetan K Sukuru; Thibaut Crepin; Youli Milev; Liesl C Marsh; Jonathan B Hill; Regan J Anderson; Jonathan C Morris; Anjali Rohatgi; Gavin O'Mahony; Morten Grøtli; Franck Danel; Malcolm G P Page; Michael Härtlein; Stephen Cusack; Michael A Kron; Leslie A Kuhn
Journal:  J Comput Aided Mol Des       Date:  2006-04-28       Impact factor: 3.686

3.  Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo.

Authors:  D A Bullough; C Zhang; A Montag; K M Mullane; M A Young
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

4.  Selective irreversible inactivation of replicating mengovirus by nucleoside analogues: a new form of viral interference.

Authors:  B Brdar; E Reich
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  Identification of the glycogenic compound 5-iodotubercidin as a general protein kinase inhibitor.

Authors:  D Massillon; W Stalmans; G van de Werve; M Bollen
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

6.  Modulation of excitatory synaptic transmission by adenosine released from single hippocampal pyramidal neurons.

Authors:  J M Brundege; T V Dunwiddie
Journal:  J Neurosci       Date:  1996-09-15       Impact factor: 6.167

Review 7.  Novel therapeutics acting via purine receptors.

Authors:  K A Jacobson; B K Trivedi; P C Churchill; M Williams
Journal:  Biochem Pharmacol       Date:  1991-05-15       Impact factor: 5.858

Review 8.  Adenosine kinase: A key regulator of purinergic physiology.

Authors:  Detlev Boison; Michael F Jarvis
Journal:  Biochem Pharmacol       Date:  2020-11-06       Impact factor: 5.858

9.  Chaperoning of the A1-adenosine receptor by endogenous adenosine - an extension of the retaliatory metabolite concept.

Authors:  Justyna Kusek; Qiong Yang; Martin Witek; Christian W Gruber; Christian Nanoff; Michael Freissmuth
Journal:  Mol Pharmacol       Date:  2014-10-29       Impact factor: 4.436

Review 10.  Pyrrolo[2,3-d]pyrimidine (7-deazapurine) as a privileged scaffold in design of antitumor and antiviral nucleosides.

Authors:  Pavla Perlíková; Michal Hocek
Journal:  Med Res Rev       Date:  2017-08-23       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.